• Exchange: Canada Ntnl
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Services

Abattis Bioceuticals Corp

+ Add to Watchlist

ATT:CN

0.5700 CAD 0.0200 3.64%

As of 15:54:30 ET on 07/25/2014.

Snapshot for Abattis Bioceuticals Corp (ATT)

Open: 0.5400 Day's Range: 0.5300 - 0.5800 Volume: 344,415
Previous Close: 0.5500 52wk Range: 0.0150 - 3.1000 1-Yr Rtn: +470.00%

Stock Chart for ATT

No chart data available.
  • ATT:CN 0.5700
  • 1D
  • 1M
  • 1Y
0.5500
Interactive ATT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -0.1529
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 27.14
Shares Outstanding (M) 47.62
30 Day Average Volume 929,783
Price/Book (mrq) 6.8047
Price/Sale (ttm) 930.5896
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATT

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ATT

Abattis Biologix Corporation researches, develops and manufactures natural botanical formulations to prevent or treat influenza strains in birds, humans and other mammals.

Michael Withrow "Mike"Chairman/President/CEOTerence Fealey "Tim"Advisor:Global Product Dev
More Company Profile & Key Executives for ATT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil